SCHEMBL17054145

SCHEMBL17054145

O=C(NS(=O)(=O)c1ccc(NC2CCN(S(=O)(=O)c3ccccc3)CC2)c(S(=O)(=O)C(F)F)c1)c1ccc(N2CCN(Cc3ccccc3-c3ccc(Cl)cc3)CC2)cc1Oc1ccccc1

nearest known ligand 0.81

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ BCL2 P10415 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1958169 0.93 BCL2 (0.62) BCL2
SCHEMBL19424690 0.91 — —
SCHEMBL1959769 0.90 BCL2 (0.72) BCL2
SCHEMBL19410469 0.88 BCL2 (0.57) BCL2
SCHEMBL19424855 0.85 — —
SCHEMBL1957126 0.84 BCL2 (0.59) BCL2
SCHEMBL2996436 0.83 BCL2 (0.74) BCL2
SCHEMBL19424630 0.83 — —
SCHEMBL1955752 0.83 BCL2 (0.76) BCL2
SCHEMBL1958976 0.82 BCL2 (0.64) BCL2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9125913-B2 Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases ABBVIE INC. (US) 2015-09-08 — — US claimed
Send feedback